DK0767172T3 - 8-arylalkyl- og 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepiner og deres anvendelse til forebyggelse eller behandling af HIV-infektion - Google Patents

8-arylalkyl- og 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepiner og deres anvendelse til forebyggelse eller behandling af HIV-infektion

Info

Publication number
DK0767172T3
DK0767172T3 DK96115901T DK96115901T DK0767172T3 DK 0767172 T3 DK0767172 T3 DK 0767172T3 DK 96115901 T DK96115901 T DK 96115901T DK 96115901 T DK96115901 T DK 96115901T DK 0767172 T3 DK0767172 T3 DK 0767172T3
Authority
DK
Denmark
Prior art keywords
arylalkyl
dihydro
prevention
treatment
hiv infection
Prior art date
Application number
DK96115901T
Other languages
English (en)
Inventor
Charles L Cywin
Maryann Hoermann
Janice M Klunder
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0767172T3 publication Critical patent/DK0767172T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK96115901T 1995-10-06 1996-10-04 8-arylalkyl- og 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepiner og deres anvendelse til forebyggelse eller behandling af HIV-infektion DK0767172T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US480695P 1995-10-06 1995-10-06
US869595P 1995-12-15 1995-12-15

Publications (1)

Publication Number Publication Date
DK0767172T3 true DK0767172T3 (da) 2003-07-21

Family

ID=26673503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96115901T DK0767172T3 (da) 1995-10-06 1996-10-04 8-arylalkyl- og 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepiner og deres anvendelse til forebyggelse eller behandling af HIV-infektion

Country Status (8)

Country Link
US (1) US5705499A (da)
EP (1) EP0767172B1 (da)
JP (1) JPH09188680A (da)
AT (1) ATE235495T1 (da)
DE (1) DE69626915T2 (da)
DK (1) DK0767172T3 (da)
ES (1) ES2191075T3 (da)
PT (1) PT767172E (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747488A (en) * 1996-01-30 1998-05-05 Boehringer Ingelheim Pharmaceuticals, Inc. 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection
GB9715584D0 (en) * 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
UA71971C2 (en) 1999-06-04 2005-01-17 Agoron Pharmaceuticals Inc Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
TWI262914B (en) * 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
US7141581B2 (en) * 1999-07-02 2006-11-28 Agouron Pharmaceuticals, Inc. Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
BR0110302A (pt) 2000-04-18 2003-01-14 Agouron Pharma Compostos de pirazol para inibição de proteìnas cinase, sal e pró-droga farmaceuticamente aceitável, metabólito farmaceuticamente ativo ou sal farmaceuticamente aceitável de metabólito, composição farmacêutica, método de tratamento de condição doentia em mamìferos mediada pela atividade de proteìna cinase, método de modulação ou inibição da atividade de um receptor de proteìna cinase
SI1294720T1 (sl) * 2000-06-16 2006-08-31 Boehringer Ingelheim Ca Ltd Nenukleozidni inhibitorji reverzne transkriptaze
TWI270547B (en) * 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) * 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en) * 2002-03-27 2004-03-16 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) * 2002-05-16 2004-10-19 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
CA2495744A1 (en) * 2002-09-19 2004-04-01 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
ES2268499T3 (es) * 2002-09-19 2007-03-16 Boehringer Ingelheim (Canada) Ltd. Inhibidores no nucleosidos de transcriptasa inveresa.
WO2004043367A2 (en) 2002-11-06 2004-05-27 Bristol-Myers Squibb Company Fused heterocyclic compounds and use thereof
EP1610782A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
AU2005233642A1 (en) * 2004-04-13 2005-10-27 Astellas Pharma Inc. Polycyclic pyridines as potassium ion channel modulators
WO2006008119A1 (en) 2004-07-16 2006-01-26 Proteosys Ag Muscarinic antagonists with parp and sir modulatng activity as agents for inflammatory diseases
EP2387405A2 (en) 2009-01-13 2011-11-23 ProteoSys AG Pirenzepine as an agent in cancer treatment
JP2017535573A (ja) 2014-11-25 2017-11-30 バイエル ファーマ アクチエンゲゼルシャフト 置換されたピリドベンゾジアゼピノン誘導体およびそれの使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
PL181323B1 (pl) * 1994-02-18 2001-07-31 Boehringer Ingelheim Pharma 2-heteroarylo-5,11-dihydro-6H-dipirydo[3,2-b:2’,3'-e][1,4] diazepinyi ich zastosowanie w zapobieganiu i leczeniu zakazen HIV PL PL PL

Also Published As

Publication number Publication date
JPH09188680A (ja) 1997-07-22
EP0767172B1 (en) 2003-03-26
US5705499A (en) 1998-01-06
DE69626915D1 (de) 2003-04-30
EP0767172A1 (en) 1997-04-09
ATE235495T1 (de) 2003-04-15
DE69626915T2 (de) 2003-11-13
PT767172E (pt) 2003-08-29
ES2191075T3 (es) 2003-09-01

Similar Documents

Publication Publication Date Title
DK0429987T3 (da) 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepiner og deres anvendelse til forebyggelse eller behandling af HIV-smitte
DE69626915D1 (de) 8-Arylalkyl- und 8-Arylheteroalkyl-5, 11-dihydro-6H-dipyrido-(3,2-b:2', 3'-e)(1,4)diazepine und ihre Verwendung zur Vorbeugung oder Behandlung von HIV-Infektion
FI955315L (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
DE69909756D1 (de) Antivirale pyrimidinderivate
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
NO20000185D0 (no) Kondenserte 1,2,4-tiadiazinderivater, deres fremstilling og anvendelse
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
DK0410148T3 (da) Hidtil ukendte 5,11-dihydro-6H-dipyrido(3,2-b:2,3-e)-(1,4)diazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS
DK0745852T3 (da) Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
DK0393529T3 (da) 5,11-Dihydro-6H-dipyrido(3,2-b:2,3-e)(1,4)diazepin-6-oner og deres anvendelse ved forhindring eller behandling af AIDS
EP0347852A3 (en) Novel neplanocin derivatives
CA2014885A1 (en) 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
DK0916670T3 (da) Pyrrolo[3,2-b]pyridiner og deres anvendelse som 5-HT1f-agonister
TW327171B (en) 2-heteroaryl-5 for prevention or treatment of HIV infection
MA25501A1 (fr) Traitement de l'endometriosis ou de la sterilite ou amelioration de la fertilite.
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
DK0393530T3 (da) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS
FI911533A7 (fi) Bentsoksatsiini-johdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö sairauksien hoitamiseen tai ennalta ehkäisemiseksi
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
NO960551D0 (no) Antistoff basert behandling av HIV infeksjon
MX9604346A (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido [3,2-b :2',3'-e] [1,4]diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.